| Year |
Citation |
Score |
| 2024 |
Frank MJ, Baird JH, Kramer AM, Srinagesh HK, Patel S, Brown AK, Oak JS, Younes SF, Natkunam Y, Hamilton MP, Su YJ, Agarwal N, Chinnasamy H, Egeler E, Mavroukakis S, et al. CD22-directed CAR T-cell therapy for large B-cell lymphomas progressing after CD19-directed CAR T-cell therapy: a dose-finding phase 1 study. Lancet (London, England). PMID 38996463 DOI: 10.1016/S0140-6736(24)00746-3 |
0.41 |
|
| 2024 |
Srinagesh HK, Jackson C, Shiraz P, Jeyakumar N, Hamilton MP, Egeler E, Mavroukakis S, Kuo A, Cancilla J, Sahaf B, Agarwal N, Kanegai AM, Kramer AM, Arai S, Bharadwaj S, ... ... Frank MJ, et al. A Phase 1 Clinical Trial of NKTR-255 with CD19-22 CAR-T Cell Therapy for Refractory B-cell Acute Lymphoblastic Leukemia. Blood. PMID 38968138 DOI: 10.1182/blood.2024024952 |
0.373 |
|
| 2024 |
Hamilton MP, Craig E, Gentille Sanchez C, Mina A, Tamaresis J, Kirmani N, Ehlinger Z, Syal S, Good Z, Sworder B, Schroers-Martin J, Lu Y, Muffly L, Negrin RS, Arai S, ... ... Frank MJ, et al. CAR19 monitoring by peripheral blood immunophenotyping reveals histology-specific expansion and toxicity. Blood Advances. PMID 38498731 DOI: 10.1182/bloodadvances.2024012637 |
0.374 |
|
| 2023 |
Shree T, Haebe SE, Czerwinski DK, Eckhert E, Day G, Sathe A, Grimes SM, Frank MJ, Maeda L, Alizadeh AA, Advani RH, Hoppe RT, Long SR, Martin BA, Ozawa MG, et al. A clinical trial of therapeutic vaccination in lymphoma with serial tumor sampling and single cell analysis. Blood Advances. PMID 37939259 DOI: 10.1182/bloodadvances.2023011589 |
0.344 |
|
| 2023 |
Younes S, Zhao S, Bharadwaj S, Mosquera AP, Libert D, Johnsrud A, Majzner RG, Miklos DB, Frank MJ, Natkunam Y. Detection of Aberrant CD58 Expression in a Wide Spectrum of Lymphoma Subtypes: Implications for Treatment Resistance. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 100256. PMID 37391168 DOI: 10.1016/j.modpat.2023.100256 |
0.337 |
|
| 2023 |
Nie EH, Ahmadian SS, Bharadwaj SN, Acosta-Alvarez L, Threlkeld ZD, Frank MJ, Miklos DB, Monje M, Scott BJ, Vogel H. Multifocal demyelinating leukoencephalopathy and oligodendroglial lineage cell loss with immune effector cell-associated neurotoxicity syndrome (ICANS) following CD19 CAR T-cell therapy for mantle cell lymphoma. Journal of Neuropathology and Experimental Neurology. PMID 36592076 DOI: 10.1093/jnen/nlac121 |
0.362 |
|
| 2022 |
Sworder BJ, Kurtz DM, Alig SK, Frank MJ, Shukla N, Garofalo A, Macaulay CWM, Shahrokh Esfahani M, Olsen MN, Hamilton J, Hosoya H, Hamilton M, Spiegel JY, Baird JH, Sugio T, et al. Determinants of resistance to engineered T cell therapies targeting CD19 in large B cell lymphomas. Cancer Cell. PMID 36584673 DOI: 10.1016/j.ccell.2022.12.005 |
0.44 |
|
| 2022 |
Good Z, Spiegel JY, Sahaf B, Malipatlolla MB, Ehlinger ZJ, Kurra S, Desai MH, Reynolds WD, Wong Lin A, Vandris P, Wu F, Prabhu S, Hamilton MP, Tamaresis JS, Hanson PJ, ... ... Frank MJ, et al. Post-infusion CAR T cells identify patients resistant to CD19-CAR therapy. Nature Medicine. PMID 36097223 DOI: 10.1038/s41591-022-01960-7 |
0.367 |
|
| 2022 |
Vu K, Frank MJ. CAR T-cell therapy for mantle cell lymphoma with central nervous system relapse. Blood Advances. PMID 35895518 DOI: 10.1182/bloodadvances.2022008031 |
0.349 |
|
| 2022 |
Esfahani MS, Hamilton EG, Mehrmohamadi M, Nabet BY, Alig SK, King DA, Steen CB, Macaulay CW, Schultz A, Nesselbush MC, Soo J, Schroers-Martin JG, Chen B, Binkley MS, Stehr H, ... ... Frank MJ, et al. Inferring gene expression from cell-free DNA fragmentation profiles. Nature Biotechnology. PMID 35361996 DOI: 10.1038/s41587-022-01222-4 |
0.347 |
|
| 2021 |
Mooney KL, Czerwinski DK, Shree T, Frank MJ, Haebe S, Martin BA, Testa S, Levy R, Long SR. Serial FNA allows direct sampling of malignant and infiltrating immune cells in patients with B-cell lymphoma receiving immunotherapy. Cancer Cytopathology. PMID 34780125 DOI: 10.1002/cncy.22531 |
0.375 |
|
| 2021 |
Frank MJ, Hossain NM, Bukhari A, Dean E, Spiegel JY, Claire GK, Kirsch I, Jacob AP, Mullins CD, Lee LW, Kong KA, Craig J, Mackall CL, Rapoport AP, Jain MD, et al. Monitoring of Circulating Tumor DNA Improves Early Relapse Detection After Axicabtagene Ciloleucel Infusion in Large B-Cell Lymphoma: Results of a Prospective Multi-Institutional Trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2100377. PMID 34133196 DOI: 10.1200/JCO.21.00377 |
0.414 |
|
| 2021 |
Baird JH, Epstein DJ, Tamaresis JS, Ehlinger Z, Spiegel JY, Craig J, Claire GK, Frank MJ, Muffly L, Shiraz P, Meyer E, Arai S, Brown JW, Johnston L, Lowsky R, et al. Immune reconstitution and infectious complications following axicabtagene ciloleucel therapy for large B-cell lymphoma. Blood Advances. 5: 143-155. PMID 33570626 DOI: 10.1182/bloodadvances.2020002732 |
0.379 |
|
| 2020 |
Baird JH, Frank MJ, Craig J, Patel S, Spiegel JY, Sahaf B, Oak JS, Younes S, Ozawa M, Yang E, Natkunam Y, Tamaresis JS, Ehlinger Z, Reynolds WD, Arai S, et al. CD22-Directed CAR T-Cell Therapy Induces Complete Remissions in CD19-Directed CAR-Refractory Large B-Cell Lymphoma. Blood. PMID 33512414 DOI: 10.1182/blood.2020009432 |
0.398 |
|
| 2020 |
Lemieux C, Johnston LJ, Lowsky R, Muffly LS, Craig JK, Shiraz P, Rezvani A, Frank MJ, Weng WK, Meyer E, Shizuru J, Arai S, Negrin R, Miklos DB, Sidana S. Outcomes with Autologous or Allogeneic Stem Cell Transplantation in Patients with Plasma Cell Leukemia in the Era of Novel Agents. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 32961371 DOI: 10.1016/J.Bbmt.2020.08.035 |
0.336 |
|
| 2020 |
Frank MJ, Khodadoust MS, Czerwinski DK, Haabeth OAW, Chu MP, Miklos DB, Advani RH, Alizadeh AA, Gupta NK, Maeda LS, Reddy SA, Laport GG, Meyer EH, Negrin RS, Rezvani AR, et al. Autologous tumor cell vaccine induces antitumor T cell immune responses in patients with mantle cell lymphoma: A phase I/II trial. The Journal of Experimental Medicine. 217. PMID 32558897 DOI: 10.1084/Jem.20191712 |
0.425 |
|
| 2020 |
Frank MJ, Olsson N, Huang A, Tang SW, Negrin RS, Elias JE, Meyer EH. A novel antibody-cell conjugation method to enhance and characterize cytokine-induced killer cells. Cytotherapy. 22: 135-143. PMID 32171435 DOI: 10.1016/J.Jcyt.2020.01.003 |
0.425 |
|
| 2019 |
Frank MJ, Hossain NM, Bukhari AA, Dean E, Spiegel JY, Claire GK, Kirsch I, Jacob A, Mullins CD, Lee LW, Kong KA, Craig JK, Mackall C, Rapoport A, Dahiya S, et al. Monitoring ctDNA in r/r DLBCL patients following the CAR T-cell therapy axicabtagene ciloleucel: Day 28 landmark analysis. Journal of Clinical Oncology. 37: 7552-7552. DOI: 10.1200/Jco.2019.37.15_Suppl.7552 |
0.375 |
|
| 2019 |
Frank MJ, Hossain N, Bukhari A, Dean E, Spiegel JY, Claire GK, Kirsch IM, Jacob AP, Mullins CD, Lee LW, Kong KA, Craig J, Mackall CL, Rapoport AP, Dahiya S, et al. Detectable Circulating Tumor DNA 28 Days after the CD19 CAR T-Cell Therapy, Axicabtagene Ciloleucel, Is Associated with Poor Outcomes in Patients with Diffuse Large B-Cell Lymphoma Blood. 134: 884-884. DOI: 10.1182/Blood-2019-132057 |
0.372 |
|
| 2019 |
Good Z, Spiegel JY, Sahaf B, Malipatlolla MB, Frank MJ, Baird J, Muffly LS, Claire GK, Craig J, Kong KA, Bendall S, Miklos DB, Mackall CL. Identification of Two CAR T-Cell Populations Associated with Complete Response or Progressive Disease in Adult Lymphoma Patients Treated with Axi-Cel Blood. 134: 779-779. DOI: 10.1182/Blood-2019-130815 |
0.416 |
|
| 2019 |
Shree T, Khodadoust MS, Czerwinski DK, Frank MJ, Hong WX, Greenstein R, Long SR, Martin B, Levy R. A Phase I/II Trial of Intratumoral CpG, Local Low-Dose Radiation, and Oral Ibrutinib in Patients with Low-Grade B-Cell Lymphoma Blood. 134: 2825-2825. DOI: 10.1182/Blood-2019-129661 |
0.46 |
|
| 2019 |
Schultz LM, Muffly LS, Spiegel JY, Ramakrishna S, Hossain N, Baggott C, Sahaf B, Patel S, Craig J, Yoon J, Kadapakkam M, Majzner RG, Frank MJ, Erickson C, Marcy AC, et al. Phase I Trial Using CD19/CD22 Bispecific CAR T Cells in Pediatric and Adult Acute Lymphoblastic Leukemia (ALL) Blood. 134: 744-744. DOI: 10.1182/Blood-2019-129411 |
0.406 |
|
| 2019 |
Sworder B, Kurtz DM, Macaulay C, Frank MJ, Alig S, Garofalo A, Sahaf B, Esfahani MS, Spiegel JY, Oak J, Beygi S, Jin MC, Chabon JJ, Khodadoust MS, Majzner RG, et al. Circulating DNA for Molecular Response Prediction, Characterization of Resistance Mechanisms and Quantification of CAR T-Cells during Axicabtagene Ciloleucel Therapy Blood. 134: 550-550. DOI: 10.1182/Blood-2019-129015 |
0.435 |
|
| 2019 |
Shree T, Khodadoust MS, Czerwinski D, Frank MJ, Hong WX, Greenstein R, Guo S, Long S, Martin BA, Levy R. Abstract CT133: Interim results of a Phase I/II trial of intratumoral CpG, local low-dose radiation, and oral ibrutinib in patients with low-grade B-cell lymphoma Cancer Research. 79. DOI: 10.1158/1538-7445.Sabcs18-Ct133 |
0.483 |
|
| 2019 |
Shree T, Khodadoust M, Czerwinski D, Frank M, Hong W, Greenstein R, Long S, Martin B, Levy R. A PHASE I/II TRIAL OF IBRUTINIB, INTRATUMORAL CPG AND LOCAL RADIATION IN PATIENTS WITH LOW-GRADE B-CELL LYMPHOMA: INTERIM CLINICAL AND CORRELATIVE RESULTS Hematological Oncology. 37: 122-123. DOI: 10.1002/Hon.82_2629 |
0.413 |
|
| 2018 |
Frank MJ, Reagan PM, Bartlett NL, Gordon LI, Friedberg JW, Czerwinski DK, Long SR, Hoppe RT, Janssen RS, Candia AF, Coffman RL, Levy R. In Situ Vaccination with a TLR 9 Agonist and Local Low Dose Radiation Induces Systemic Responses in Untreated Indolent Lymphoma. Cancer Discovery. PMID 30154192 DOI: 10.1158/2159-8290.Cd-18-0743 |
0.391 |
|
| 2018 |
Czerwinski DK, Frank MJ, Shree T, Khodadoust MS, Long SR, Levy R. Intratumoral Injection of CpG-ODN Plus Systemic Ibrutinib Induces an Anti-Tumor Immune Response Affecting T Cell Subsets in the Microenvironment of Both Injected and Non-Injected Tumor Sites in Patients with Low-Grade Lymphoma Blood. 132: 1612-1612. DOI: 10.1182/Blood-2018-99-119931 |
0.478 |
|
| 2018 |
Spiegel JY, Sahaf B, Hossain N, Frank MJ, Claire G, Abramian M, Latchford T, Villa B, Cancilla J, Oak J, Natkunam Y, Long SR, Arai S, Johnston LJ, Lowsky R, et al. Elevated Axicabtagene Ciloleucel (CAR-19) Expansion By Immunophenotyping Is Associated with Toxicity in Diffuse Large B-Cell Lymphoma Blood. 132: 576-576. DOI: 10.1182/Blood-2018-99-113261 |
0.409 |
|
| 2018 |
Hossain N, Sahaf B, Abramian M, Spiegel JY, Kong K, Kim S, Mavroukakis S, Oak J, Natkunam Y, Meyer EH, Frank MJ, Feldman SA, Long SR, Qin H, Fry TJ, et al. Phase I Experience with a Bi-Specific CAR Targeting CD19 and CD22 in Adults with B-Cell Malignancies Blood. 132: 490-490. DOI: 10.1182/Blood-2018-99-110142 |
0.421 |
|
| 2017 |
Frank MJ, Huang A, Tang S, Negrin RS, Hsiao S, Meyer EH. A Novel Antibody-Cell Conjugation Method to Enhance Cellular Therapies for the Treatment of Hematological Malignancies Blood. 130: 1532-1532. DOI: 10.1182/Blood.V130.Suppl_1.1532.1532 |
0.492 |
|
| 2017 |
Frank M, Khodadoust M, Chu M, Kohrt H, Advani R, Alizadeh A, Reddy S, Maeda L, Gupta N, Laport G, Meyer E, Miklos D, Negrin R, Rezvani A, Weng W, et al. PHASE I/II CLINICAL TRIAL OF AN ACTIVATED WHOLE TUMOR CELL VACCINE FOLLOWED BY TRANSFER OF IMMUNE T CELLS IN PATIENTS WITH MANTLE CELL LYMPHOMA Hematological Oncology. 35: 207-208. DOI: 10.1002/Hon.2438_72 |
0.426 |
|
| 2016 |
Levy R, Reagan PM, Friedberg JW, Bartlett NL, Gordon LI, Leung A, Peterkin J, Xing B, Coffman R, Janssen R, Candia A, Khodadoust M, Frank MJ, Long SR, Czerwinski DK, et al. SD-101, a Novel Class C CpG-Oligodeoxynucleotide (ODN) Toll-like Receptor 9 (TLR9) Agonist, Given with Low Dose Radiation for Untreated Low Grade B-Cell Lymphoma: Interim Results of a Phase 1/2 Trial Blood. 128: 2974-2974. DOI: 10.1182/Blood.V128.22.2974.2974 |
0.386 |
|
| 2016 |
Czerwinski DK, Long SR, Khodadoust M, Frank MJ, Kardosh A, Okada A, Robinson S, Levy R. Examining the Heterogeneity of Follicular Lymphoma By Multi-Parameter Flow Cyotmetry in Previously Untreated Patients Blood. 128: 2947-2947. DOI: 10.1182/Blood.V128.22.2947.2947 |
0.547 |
|
| 2016 |
Levy R, Bartlett N, Friedberg J, Reagan P, Gordon L, Bergman C, Coffman R, Janssen R, Candia A, Khodadoust M, Frank M, Long S, Czerwinski D, Chu M, Kohrt H. Abstract CT047: SD-101, a novel intratumoral class C CpG-ODN, given with low-dose radiation in patients with untreated low-grade B-cell lymphoma: interim results of a phase I trial Cancer Research. 76. DOI: 10.1158/1538-7445.Am2016-Ct047 |
0.406 |
|
| 2015 |
Czerwinski DK, Long SR, Khodadoust M, Frank MJ, Chu MP, Okada A, McDonald KA, Kohrt HE, Bartlett NL, Reagan PM, Friedberg JW, Gordon LI, Coffman R, Janssen R, Levy R. Regulatory T Cells Are Depleted in Low-Grade Lymphoma By the Combination of Local Low-Dose Radiation Followed By Intratumoral CpG-ODN Blood. 126: 1539-1539. DOI: 10.1182/Blood.V126.23.1539.1539 |
0.493 |
|
| 2015 |
Chu MP, Brody J, Kohrt HE, Frank MJ, Khodadoust M, Reddy S, Advani RH, Gupta NK, Laport G, Maeda LS, Meyer E, Miklos DB, Negrin R, Rezvani AR, Weng W, et al. Phase I/II Clinical Trial of CpG-Activated Whole Cell Vaccine in Mantle Cell Lymphoma (MCL): Results in Safety and Efficacy from Planned Interim Analysis Blood. 126: 1536-1536. DOI: 10.1182/Blood.V126.23.1536.1536 |
0.441 |
|
| 2011 |
Aaltonen T, Álvarez González B, Amerio S, Amidei D, Anastassov A, Annovi A, Antos J, Apollinari G, Appel JA, Apresyan A, Arisawa T, Artikov A, Asaadi J, Ashmanskas W, Auerbach B, ... Frank MJ, et al. Search for B(s)(0) → μ+ μ- and B(0) → μ+ μ- decays with CDF II. Physical Review Letters. 107: 191801. PMID 22181596 DOI: 10.1103/Physrevlett.107.191801 |
0.318 |
|
| 2009 |
Balatoni CE, Dawson DW, Suh J, Sherman MH, Sanders G, Hong JS, Frank MJ, Malone CS, Said JW, Teitell MA. Epigenetic silencing of Stk39 in B-cell lymphoma inhibits apoptosis from genotoxic stress. The American Journal of Pathology. 175: 1653-61. PMID 19717643 DOI: 10.2353/Ajpath.2009.090091 |
0.62 |
|
| 2009 |
Frank MJ, Dawson DW, Bensinger SJ, Hong JS, Knosp WM, Xu L, Balatoni CE, Allen EL, Shen RR, Bar-Sagi D, Martin GR, Teitell MA. Expression of sprouty2 inhibits B-cell proliferation and is epigenetically silenced in mouse and human B-cell lymphomas. Blood. 113: 2478-87. PMID 19147787 DOI: 10.1182/Blood-2008-05-156943 |
0.622 |
|
| 2008 |
Reed J, Frank M, Troke JJ, Schmit J, Han S, Teitell MA, Gimzewski JK. High throughput cell nanomechanics with mechanical imaging interferometry. Nanotechnology. 19: 235101. PMID 20737027 DOI: 10.1088/0957-4484/19/23/235101 |
0.536 |
|
| 2008 |
Reed J, Frank M, Troke JJ, Schmit J, Han S, Teitell MA, Gimzewski JK. Imaging interferometry for investigation of mechanics of multiple cells in a large field of view Optics Infobase Conference Papers. |
0.514 |
|
| 2007 |
Fagone P, Sriburi R, Ward-Chapman C, Frank M, Wang J, Gunter C, Brewer JW, Jackowski S. Phospholipid biosynthesis program underlying membrane expansion during B-lymphocyte differentiation. The Journal of Biological Chemistry. 282: 7591-605. PMID 17213195 DOI: 10.1074/Jbc.M608175200 |
0.321 |
|
| Show low-probability matches. |